Nora Kayton Bryant, PhD

Nora Kayton Bryant, PhD

Nora Kayton Bryant, PhD, ACRP® received her PhD in Molecular Physiology & Biophysics from Vanderbilt University in 2015. Her doctoral work defined direct effects of glucose toxicity on in vivo human beta cell function and transcription factor expression, in the laboratory of Al Powers, MD. In 2016, Dr. Bryant began a postdoctoral fellowship at the Joslin Diabetes Center, with Jason Gaglia, MD, working on clinical research protocols related to screening, prevention, and treatment of pediatric- and adult-onset type 1 diabetes. In 2018, Dr. Bryant became the Clinical Trials Manager for Dr. Gaglia’s entire clinical research portfolio, overseeing all regulatory, operational, and personnel aspects of investigator-initiated and industry-sponsored research. In addition, Dr. Bryant contributes to protocol design and authorship of manuscript and study-related documents. Some of her primary intellectual interests are the principles of trail design and trial conduct.